PMA device
Pmp
Abbott Medical · Dorsal Root Ganglion Stimulator For Pain Relief (PMP, Class III) · First FDA decision Feb 3, 2017, newest Feb 3, 2017Chronic pain
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
3
Naming "Pmp"
MAUDE reports
601
Brand "Pmp", since 2015
PubMed studies
3,888
Mentioning "Pmp"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Pmp
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- PMPPMA supplement
P150004-S006 · Decided Feb 3, 2017 · 88 days after receipt · Normal 180 Day Track
Device type: Dorsal root ganglion stimulator for pain relief (PMP) · Neurology & Neurosurgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Pmp", any status and sponsor, newest update first.
- The Role of Neurofeedback Training and Pain Management in Post-operative Shoulder RehabilitationWithdrawn
Chang Gung Memorial HospitalAcademic, hospital or other
NCT05948007 · 0 participants · Start Nov 1, 2023 · Primary completion May 21, 2026
Device: Neurofeedback training; Sham-neurofeedback training · For: Pain, Shoulder; Post Operative Pain
Chang Gung UniversityAcademic, hospital or other
NCT04522518 · 538 participants · Start Aug 1, 2019 · Primary completion Oct 30, 2021
Device: PmP-C App · For: Developmental Disability
Sites: Taoyuan, Taiwan
- A Longitudinal Quantitative Assessment of the Effectiveness of Metatarsal Pads on Plantar PressuresStatus unknown
University Health Network, TorontoAcademic, hospital or other
NCT04336514 · 40 participants (planned) · Start Mar 6, 2020 · Primary completion May 31, 2021
Device: Semi-compressed felt pad (SCF) · For: Forefoot Callus; Podiatry; Foot Dermatoses and 1 more
Sites: Toronto, Canada
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Pmp", and for the whole product code for context.
This brand
601 reports: 480 malfunction, 115 injury, 6 death
Whole product code PMP
20,258 reports: 250 malfunction, 19,968 injury, 32 death
Newest reports for this brand
- Advanced Membrane Gas Exchange PMP SterileMalfunction
3003752502-2026-00050 · Received Oct 23, 2026 · Event dated Sep 25, 2026
Device type: Oxygenator, Cardiopulmonary Bypass (DTZ)
Device problem as coded: Electrical /Electronic Property Problem; Mechanical Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- Advanced Membrane Gas Exchange PMP SterileMalfunction
3003752502-2026-00049 · Received Oct 19, 2026 · Event dated Sep 28, 2026
Device type: Oxygenator, Cardiopulmonary Bypass (DTZ)
Device problem as coded: Electrical /Electronic Property Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- Advanced Membrane Gas Exchange PMP SterileMalfunction
3003752502-2026-00048 · Received Oct 19, 2026 · Event dated Sep 28, 2026
Device type: Oxygenator, Cardiopulmonary Bypass (DTZ)
Device problem as coded: Electrical /Electronic Property Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Pmp"[tiab]. The summary above synthesizes these.
- NINJ1 is activated by cell swelling to regulate plasma membrane permeabilization during regulated necrosis.
Dondelinger Y, Priem D, Huyghe J, et al. · Cell Death Dis · 2023Research Support, Non-U.S. Gov't
- PMP-Net++: Point Cloud Completion by Transformer-Enhanced Multi-Step Point Moving Paths.
Wen X, Xiang P, Han Z, et al. · IEEE Trans Pattern Anal Mach Intell · 2023
- Probe my Pathway (PmP): a portal to explore the chemical coverage of the human Reactome.
Kwak HA, Liu L, Schapira M · Database (Oxford) · 2024Research Support, Non-U.S. Gov't
- Effects of medium pH on the yeast plasma membrane potential.
Peña A, Sánchez NS, Ramiro-Cortés Y, et al. · Arch Biochem Biophys · 2024Research Support, Non-U.S. Gov't
- Chemical Glycosylation with p-Methoxyphenyl (PMP) Glycosides via Oxidative Activation.
Kim HS, Jang E, Kim HI, et al. · Org Lett · 2023
- Progress on immuno-microenvironment and immune-related therapies in patients with pseudomyxoma peritonei.
Zhao Q, Wei T, Ma R, et al. · Cancer Biol Med · 2024Review, Research Support, Non-U.S. Gov't
- Pseudomyxoma peritonei: natural history and treatment.
Mittal R, Chandramohan A, Moran B · Int J Hyperthermia · 2017Review
- Precision Oncology and Systemic Targeted Therapy in Pseudomyxoma Peritonei.
Martínez-Quintanilla J, Cabot D, Sabia D, et al. · Clin Cancer Res · 2024
- Characterization of the BspA and Pmp protein family of trichomonads.
Handrich MR, Garg SG, Sommerville EW, et al. · Parasit Vectors · 2019
- The PMP Requirement Begins.
Berlin J · Tex Med · 2020
- The peripheral myelin gene PMP-22/GAS-3 is duplicated in Charcot-Marie-Tooth disease type 1A.
Valentijn LJ, Bolhuis PA, Zorn I, et al. · Nat Genet · 1992Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
- Assessment of the microvasculature in poppers maculopathy.
Hamann T, Wiest MRJ, Brinkmann M, et al. · Graefes Arch Clin Exp Ophthalmol · 2022
Other devices of this type
Also filed under product code PMP.
- Axium Neurostimulator SystemAbbott Medical · PMA 2024
- Proclaim DRG IPG (Model 3664)Abbott Medical · PMA 2023
- Proclaim Dorsal Root Ganglion (DRG) Neurostimulator SystemAbbott Medical · PMA 2026
- Dorsal Root Ganglion (DRG) Neurostimulation SystemAbbott Medical · PMA 2025
- SlimTip Dorsal Root Ganglion (DRG) Trial Lead KitAbbott Medical · PMA 2025
- Family of DRG IPGsAbbott Medical · PMA 2024
- NextGen DRG Lead Kit and AccessoriesAbbott Medical · PMA 2021
- Proclaim SCS Neurostimulator SystemAbbott Medical · PMA 2021
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.